Evidence map›Paper›PMID 34401721›Full record

ArticleKidney medicine

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies.

Kristen L Nowak, Kaleigh Murray, Zhiying You, Berenice Gitomer, Godela Brosnahan, Kaleab Z Abebe, William Braun, Arlene Chapman, Peter C Harris, Dana Miskulin and 5 more

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. How Does ADPKD Severity Differ Between Family Members?Kidney international reports · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Kristen L NowakUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
Kaleigh MurrayUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
Zhiying YouUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
Berenice GitomerUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
Godela BrosnahanUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
Kaleab Z AbebeUniversity of Pittsburgh, Pittsburgh, PA.
William BraunCleveland Clinic, Cleveland, OH.
Arlene ChapmanUniversity of Chicago Medicine, Chicago, IL.
Peter C HarrisMayo Clinic, Rochester, MN.
Dana MiskulinTufts Medical Center, Boston, MA.
Ronald PerroneTufts Medical Center, Boston, MA.
Vicente TorresMayo Clinic, Rochester, MN.
Theodore SteinmanBeth Israel Deaconess Medical Center, Boston, MA.
Alan YuUniversity of Kansas Medical Center, Kansas City, KS.
Michel ChoncholUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
University of Colorado Anschutz Medical Campus · USMayo Clinic in Arizona · USTufts Medical Center · USCleveland Clinic · USEmory University · USUniversity of Chicago · USUniversity of Kansas Medical Center · USUniversity of Pittsburgh · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BRYAN C BERGMAN · 1995 to 2026
$32.6M
NCATS NIH HHS UL1 TR000001NCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR001064NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR001102NCATS NIH HHS UL1 TR002544NCATS NIH HHS UL1 TR002548NCRR NIH HHS M01 RR000039NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR000054NCRR NIH HHS M01 RR000585NCRR NIH HHS M01 RR001032NCRR NIH HHS M01 RR023940NCRR NIH HHS UL1 RR024150NCRR NIH HHS UL1 RR024989NCRR NIH HHS UL1 RR025008NCRR NIH HHS UL1 RR025752NCRR NIH HHS UL1 RR025758NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1 RR033179NIDDK NIH HHS K01 DK103678NIDDK NIH HHS P30 DK048520NIDDK NIH HHS P30 DK090868NIDDK NIH HHS R03 DK118215NIDDK NIH HHS U01 DK062401NIDDK NIH HHS U01 DK062402NIDDK NIH HHS U01 DK062408NIDDK NIH HHS U01 DK062410NIDDK NIH HHS U01 DK082230NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

RATIONALE &

objectivePain is a frequent complication of autosomal dominant polycystic kidney disease (ADPKD) and includes back and abdominal pain. We hypothesized that in adults with early- and late-stage ADPKD, overweight and obesity are independently associated with greater self-reported back, abdominal, and radicular pain at baseline and that weight loss would be associated with decreased pain over a follow-up period. STUDY

designPost hoc analysis of pooled data from 2 randomized trials. SETTING &

participantsParticipants in the HALT-PKD study A or B. 867 individuals were included in a cross-sectional analysis. 4,248 observations from 871 participants were included in a longitudinal analysis. PREDICTOR: Overweight and obesity (cross-sectional); annual change in weight as a time-varying predictor (longitudinal). OUTCOME: Pain (Likert-scale responses; cross-sectional); annual change in pain (binary outcome of worsening pain or not worsening; longitudinal). ANALYTICAL APPROACH: Multivariable ordinal logistic regression (cross-sectional); generalized estimating equation analysis (longitudinal).

resultsParticipants were aged 42±10 years and baseline estimated glomerular filtration rate was 71±26 mL/min/1.73 m LIMITATIONS: Post hoc, associative analysis.

conclusionsIn early- and late-stage ADPKD, obesity was associated with greater back and radicular pain independent of total kidney/liver volume. Mild weight loss was associated with favorable effects on back pain.

Indexed as

Body mass indexobesitypainpolycystic kidney diseaseweight loss

Identifiers

PMID34401721
PMCPMC8350824
OpenAlexW3159084863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.